A new method measures the immune cell response within minutes

May 30, 2018, Universitaet Tübingen
The new method identifies structural changes in the integrins, certain molecules expressed on the cell surface of the T cells, and thus detects whether the T lymphocytes are working effectively. Credit: Stoyan Dimitrov

T cells fight pathogens and tumors: Researchers from the Universities of Tübingen and Lübeck present a simple and fast method to rapidly assess their function.

To fight pathogens or tumors, the body relies on various types of , including T , which recognize specific structures (antigenic peptides) on altered cells which are presented on specialized cell surface molecules called HLA. A new study presents a with which the T-cell can be assessed in a very short time after blood drawing. A research team headed by Prof. Dr. Jan Born of the Institute for Medical Psychology and Behavioral Neurobiology and Prof. Dr. Hans-Georg Rammensee of the Interfaculty Institute for Cell Biology at the University of Tübingen and by Dr. Tanja Lange of the Clinic for Rheumatology and Clinical Immunology at the University of Lübeck has established this novel method. Due to its simplicity, reliability and versatility, it could be broadly implemented for basic research and in the clinical setting. The results of the study were published in Proceedings of the National Academy of Science (PNAS).

T lymphocytes as well as B lymphocytes are cells of the immune system specialized in fighting pathogens. In order to assess how well the immune works, the antibodies produced by the B lymphocytes and released into the blood can be easily measured by well-established methods. However, to fight many infections or cancer, a good T-cell response is crucial; new cancer immunotherapies are also often based on a T-cell-dependent immune response that detects and kills abnormal body cells. The methods used so far to test this T-cell response are technically cumbersome and time-consuming and are therefore used only to a limited extent in research and daily patient care.

The new method can be used to check whether a vaccine has worked, as shown in the publication with the yellow fever vaccine. The measurement, taken two weeks after vaccination, takes only a few minutes. Credit: Christoph Jäckle/University of Tübingen
"This could be a game-changing method," says Dr. Stoyan Dimitrov, first author of the study. The method recognizes the antigen-specific T lymphocytes within a very short time by identifying structural changes of the so-called integrins, a type of molecules expressed on the cell surface of T cells. "Our method could rapidly replace the techniques in use for measuring functional T cells. It is much faster and easier to perform, and does not require sophisticated reagents," says Dimitrov. "We have successfully applied the method in two different studies into the role of sleep in fighting chronic infection – with the cytomegalovirus – and in enhancing vaccination efficiency – against the yellow fever virus," says Jan Born.

T lymphocytes play a key role in many infections, such as malaria, HIV, tuberculosis, herpes and hepatitis. "Still, T cell-mediated immunity is currently routinely assessed only for tuberculosis," says Tanja Lange. "Our new method could be widely used," adds researcher Dr. Cécile Gouttefangeas. "It is also suitable for faster and accurate monitoring of T-cell immune responses in cancer patients, as well as to test the efficacy of novel immunotherapies such as experimental cancer vaccines or so-called checkpoint inhibitors." "The method could be also used to isolate functional anti-tumor T cells for anti-cancer adoptive cell-transfer immunotherapy," adds Hans-Georg Rammensee.

Explore further: Scientists find the key to improved cancer immunotherapy

More information: Stoyan Dimitrov et al. Activated integrins identify functional antigen-specific CD8+T cells within minutes after antigen stimulation, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1720714115

Related Stories

Scientists find the key to improved cancer immunotherapy

July 18, 2017
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) have investigated how different subtypes of essential immune-response cells called CD8+ T lymphocytes cooperate to mount a stronger ...

Unique approach to treatment of rare and aggressive blood cancers

November 14, 2017
A unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and difficult-to-treat family of cancers, finds a study involving researchers from Cardiff University.

Researchers discover new approach to stimulate an immune response against tumor cells

January 30, 2018
New drugs that activate the immune system to target cancer cells have improved the lives of many patients with cancer. However, immunotherapies are not effective in all patients, and the success of these therapies depends ...

Hunting for immune cells' cancer targets

December 21, 2017
By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer.

T cell channel could be targeted to treat head and neck cancers

November 17, 2016
Researchers at the University of Cincinnati (UC) have discovered that an ion channel, active within T cells (white blood cells), could be targeted to reduce the growth of head and neck cancers.

Researchers makes 'natural born killer' cell discovery

August 31, 2017
An unexpected role for a white blood cell called the Natural Killer (NK) cell - a critical cell for ridding the body of infection and cancer, has been discovered by researchers at New Zealand's University of Otago.

Recommended for you

Scientists create device to deliver immunotherapy without side effects

October 23, 2018
Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this nanofluidic seed makes it possible to deliver ...

Covert tactics used by bacteria to trick human immune system

October 23, 2018
McMaster University researchers have found a new way bacteria evade the human immune system and promote infection.

Machine learning tool predicts the potential of peptides as immune activators

October 23, 2018
The immune system keeps T cells under control by regulating precisely when they can respond to a pathogen. For instance, helper T cells only turn "on" if other immune cells, such as antigen-presenting cells (APCs) present ...

Antibodies linked to heart attacks

October 23, 2018
Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity, a study from Karolinska Institutet in Sweden published in ...

Protein found in patients with severe asthma can help identify who would benefit from targeted drugs

October 22, 2018
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways. These patients with the type 2 (T2) endotype may benefit ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.